Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
Recruiting · NCT06542237 · Registry updated 2026-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Site, Neoplasms, Multiple Primary, endocrine system disorder, hereditary disease, hereditary neoplastic syndrome, malignant endocrine neoplasm, multiple endocrine neoplasia, multiple endocrine neoplasia type 1, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-02-13 | NCT06542237 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| YourChoice Therapeutics, Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| New Zealand Clinical Research (NZCR) | Grafton | New Zealand | 4 |